Health Professionals News

Trial update: NABNEC The NABNEC trial is almost halfway to its accrual target, with 31 participants at the end... Read More

Dear Members, At the beginning of this month I attended the ASCO Annual Meeting in Chicago. At the meeting... Read More

Trial news: The AGITG currently has thirteen studies open to recruitment and five studies in follow up. The... Read More

The preliminary results of the ALT-GIST clinical trial were released at the ASCO Annual Meeting. ALT-GIST was a phase... Read More

Dear Members, Monday 20 May was International Clinical Trials Day. This was an opportunity to reflect on the dedication... Read More

ALT-GIST results to be presented at ASCO The preliminary results of the phase II ALT-GIST study will be presented... Read More

The Clinical Oncology Society of Australia (COSA) Cancer Survivorship Conference was held from 28-29 March. The event hosted... Read More

AGITG Joint Working Party Meeting 10 May 2019 May 22, 2019 Lower GI Working Party Trial Updates SPAR recruitment is underway... Read More

Clinical trial sites actively involved in AGITG Studies are invited to submit a brief application of 500 words... Read More

APOLLO1: Australian Peritoneal Organoid guided therapy to Lengthen Life in patients without Opportunity for Cure: a pilot trial. This... Read More

The DYNAMIC Studies AGITG currently has three studies investigating ctDNA in gastro-intestinal cancers. The three trials will help determine... Read More

The first AGITG trial site in Japan has opened for the INTEGRATE II study in gastro-oesophageal cancer. National Cancer... Read More

The John Zalcberg OAM Award for Excellence in AGITG Research Pictured – L to R: Professor Tim Price AGITG... Read More

Concept Updates from previous meetings: NAP CAPABIL: Single arm phase II trial of NAB-paclitaxel in combination with capecitabine as second-line... Read More

The GI Cancer Institute’s research and clinical trials are developed through a robust, scientific process. The studies we... Read More

Professor Tim Price, Chair of the GI Cancer Institute, will lead the Gutsy Southern Alps Challenge in New... Read More

During 2017 our Board of Directors and management created a revised Strategic Plan for the organisation and its... Read More

Excellence in gastro-intestinal (GI) cancer research and treatment has been recognised on the Australia Day 2019 Honours List,... Read More

The Department of Health has announced on Saturday 1 December that five new cancer listings have been made... Read More

Dr David Lau is three months into his fellowship at Royal Marsden Hospital, London. “It has been incredible,” he... Read More